Water soluble cannabis composition
The invention provides a water-soluble composition comprising cannabis extract. The invention also provides methods of producing a water-soluble composition comprising cannabis extract. The invention further provides a solution comprising cannabis extract. Furthermore, the invention provides a frozen composition, a medication, a pharmaceutical composition, and a kit comprising a water-soluble composition comprising cannabis extract.
1. A synthetic cannabis formulation consisting essentially of synthetic cannabis, coconut flour, isomalt, a starch selected from the group consisting of corn starch, potato starch, arrowroot starch and mixtures thereof.
2. The composition of claim 1 , wherein the isomalt is isomalt 721, isomalt 801 or a mixture thereof.
3. The composition of claim 1 , wherein the synthetic cannabis consists essentially of a mixture of synthetic cannabinoids.
4. The composition of claim 3 , wherein the mixture of synthetic cannabinoids are selected from the group consisting of tetrahydrocannabinol, tetrahydrocannabinolic acid, cannabidiol, cannabidiolic acid, cannabinol, cannabigerol, cannabichromene, cannabicyclol, cannabivarin, tetrahydrocannabivarin, cannabidivarin, cannabichromevarin, cannabigerovarin, cannabigerol monomethyl ether, cannabielsoin, and cannabicitran.
5. The composition of claim 4 , wherein the mixture of synthetic cannabinoids are two selected from the group consisting of selected from tetrahydrocannabinol, tetrahydrocannabinolic acid, cannabidiol, cannabidiolic acid, cannabinol, cannabigerol, cannabichromene, cannabicyclol, cannabivarin, tetrahydrocannabivarin, cannabidivarin, cannabichromevarin, cannabigerovarin, cannabigerol monomethyl ether, cannabielsoin, and cannabicitran.
6. The composition of claim 5 , wherein the two components are selected from the group consisting of tetrahydrocannabinol, tetrahydrocannabinolic acid, cannabidiol, cannabidiolic acid, cannabinol, cannabigerol, cannabichromene, cannabicyclol, cannabivarin, tetrahydrocannabivarin, cannabidivarin, cannabichromevarin, cannabigerovarin, cannabigerol monomethyl ether, cannabielsoin, and cannabicitran, are in a ratio of about 1:20.
7. The composition of claim 5 , wherein the two components are selected from the group consisting of tetrahydrocannabinol, tetrahydrocannabinolic acid, cannabidiol, cannabidiolic acid, cannabinol, cannabigerol, cannabichromene, cannabicyclol, cannabivarin, tetrahydrocannabivarin, cannabidivarin, cannabichromevarin, cannabigerovarin, cannabigerol monomethyl ether, cannabielsoin, and cannabicitran, are in a ratio of about 1:10.
8. The composition of claim 5 , wherein the two components are selected from the group consisting of tetrahydrocannabinol, tetrahydrocannabinolic acid, cannabidiol, cannabidiolic acid, cannabinol, cannabigerol, cannabichromene, cannabicyclol, cannabivarin, tetrahydrocannabivarin, cannabidivarin, cannabichromevarin, cannabigerovarin, cannabigerol monomethyl ether, cannabielsoin, and cannabicitran, are in a ratio of about 1:1.
9. The composition of claim 1 , further consisting essentially of a terpenoid or a mixture of terpenoids.
10. The composition of claim 9 , wherein the terpenoid is selected from the group consisting of alpha-bisabolol, borneol, alpha-caryophyllene, beta-caryophyllene, alpha elemene, beta elemene, gamma elemene, delta elemene, limonene, camphene, camphor, delta-3-carene, caryophyllene oxide, alpha-cedreen, citral, eucalyptol, beta-eudesmol, eudesm-7(11)-en-4-ol, farnesene, fenchol, alpha-guaiene, geraniol, guaiol, germacrene B, guaia-1(10)-11-diene, humulene, alpha-humulene, isobomeol, linalool, menthol, myrcene, alpha-myrcene, beta-myrcene, nerol, cis-ocimene, trans-ocimene, alpha-phellandrene, alpha-pinene, beta-pinene, pulegone, sabinene, alpha-terpinene, alpha-terpineol, terpinolene, terpineol, thymol, trans-2-pinanol, selina-3,7(1)-diene, valencene and mixtures thereof.
11. The composition of claim 1 , wherein the formulation is water soluble.
12. A solution consisting essentially of the formulation of claim 1 .
13. A frozen composition consisting essentially of the formulation of claim 1 .
14. A medicament consisting essentially of the formulation of claim 1 .
15. A pharmaceutical composition consisting essentially of the formulation of claim 1 .
16. A kit consisting essentially of the formulation of claim 1 .
17. A method of producing the formulation of claim 1 , consisting essentially of:
mixing synthetic cannabis with isomalt to make a first mixture;
combining the first mixture with coconut flour to make a second mixture;
mixing the second mixture with starch to make a third mixture;
drying the third mixture; and
sifting the dried third mixture through a mesh, thereby producing the formulation of claim 1 .
18. The method of claim 17 , wherein the synthetic cannabis consists essentially of a mixture of cannabinoids.
19. The method of claim 18 , wherein the cannabinoids are selected from the group consisting of tetrahydrocannabinol, tetrahydrocannabinolic acid, cannabidiol, cannabidiolic acid, cannabinol, cannabigerol, cannabichromene, cannabicyclol, cannabivarin, tetrahydrocannabivarin, cannabidivarin, cannabichromevarin, cannabigerovarin, cannabigerol monomethyl ether, cannabielsoin, and cannabicitran.
20. The method of claim 19 , wherein the components are two selected from the group consisting of tetrahydrocannabinol, tetrahydrocannabinolic acid, cannabidiol, cannabidiolic acid, cannabinol, cannabigerol, cannabichromene, cannabicyclol, cannabivarin, tetrahydrocannabivarin, cannabidivarin, cannabichromevarin, cannabigerovarin, cannabigerol monomethyl ether, cannabielsoin, and cannabicitran.
21. The method of claim 19 , wherein the components are two selected from the group consisting of tetrahydrocannabinol, tetrahydrocannabinolic acid, cannabidiol, cannabidiolic acid, cannabinol, cannabigerol, cannabichromene, cannabicyclol, cannabivarin, tetrahydrocannabivarin, cannabidivarin, cannabichromevarin, cannabigerovarin, cannabigerol monomethyl ether, cannabielsoin, and cannabicitran, in a ratio of about 1:20.
22. The method of claim 19 , wherein the components are two selected from the group consisting of tetrahydrocannabinol, tetrahydrocannabinolic acid, cannabidiol, cannabidiolic acid, cannabinol, cannabigerol, cannabichromene, cannabicyclol, cannabivarin, tetrahydrocannabivarin, cannabidivarin, cannabichromevarin, cannabigerovarin, cannabigerol monomethyl ether, cannabielsoin, and cannabicitran, in a ratio of about 1:10.
23. The method of claim 19 , wherein the components are two selected from the group consisting of tetrahydrocannabinol, tetrahydrocannabinolic acid, cannabidiol, cannabidiolic acid, cannabinol, cannabigerol, cannabichromene, cannabicyclol, cannabivarin, tetrahydrocannabivarin, cannabidivarin, cannabichromevarin, cannabigerovarin, cannabigerol monomethyl ether, cannabielsoin, and cannabicitran, in a ratio of about 1:1.
24. The method of claim 17 , further consisting essentially of a terpenoid or a mixture of terpenoids.
25. The method of claim 24 , wherein the terpenoid is selected from the group consisting of alpha-bisabolol, borneol, alpha-caryophyllene, beta-caryophyllene, alpha elemene, beta elemene, gamma elemene, delta elemene, limonene, camphene, camphor, delta-3-carene, caryophyllene oxide, alpha-cedreen, citral, eucalyptol, beta-eudesmol, eudesm-7(11)-en-4-ol, farnesene, fenchol, alpha-guaiene, geraniol, guaiol, germacrene B, guaia-1(10)-11-diene, humulene, alpha-humulene, isobomeol, linalool, menthol, myrcene, alpha-myrcene, beta-myrcene, nerol, cis-ocimene, trans-ocimene, alpha-phellandrene, alpha-pinene, beta-pinene, pulegone, sabinene, alpha-terpinene, alpha-terpineol, terpinolene, terpineol, thymol, trans-2-pinanol, selina-3,7(1)-diene, valencene and mixtures thereof.
26. The method of claim 17 , wherein the coconut flour is a powder.